TY - JOUR
T1 - Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity
T2 - The optimal care study
AU - Taher, Ali T.
AU - Musallam, Khaled M.
AU - Karimi, Mehran
AU - El-Beshlawy, Amal
AU - Belhoul, Khawla
AU - Daar, Shahina
AU - Saned, Mohamed Salaheldin
AU - El-Chafic, Abdul Hamid
AU - Fasulo, Maria R.
AU - Cappellini, Maria D.
PY - 2010/3/11
Y1 - 2010/3/11
N2 - Despite recent advances in understanding the pathophysiologic mechanisms behind the thalassemia intermedia (TI) phenotype, data on the effects of treatment are deficient. To provide such data, we evaluated 584 TI patients for the associations between patient and disease characteristics, treatment received, and the rate of complications. The most common disease-related complications were osteoporosis, extramedullary hematopoeisis (EMH), hypogonadism, and cholelithiasis, followed by thrombosis, pulmonary hypertension (PHT), abnormal liver function, and leg ulcers. Hypothyroidism, heart failure, and diabetes mellitus were less frequently observed. On multivariate analysis, older age and splenectomy were independently associated with an increased risk of most disease-related complications. Transfusion therapy was protective for thrombosis, EMH, PHT, heart failure, cholelithiasis, and leg ulcers. However, transfusion therapy was associated with an increased risk of endocrinopathy. Iron chelation therapy was in turn protective for endocrinopathy and PHT. Hydroxyurea treatment was associated with an increased risk of hypogonadism yet was protective for EMH, PHT, leg ulcers, hypothyroidism, and osteoporosis. Attention should be paid to the impact of age on complications in TI, and the beneficial role of splenectomy deserves revisiting. This study provides evidence that calls for prospective evaluation of the roles of transfusion, iron chelation, and hydroxyurea therapy in TI patients.
AB - Despite recent advances in understanding the pathophysiologic mechanisms behind the thalassemia intermedia (TI) phenotype, data on the effects of treatment are deficient. To provide such data, we evaluated 584 TI patients for the associations between patient and disease characteristics, treatment received, and the rate of complications. The most common disease-related complications were osteoporosis, extramedullary hematopoeisis (EMH), hypogonadism, and cholelithiasis, followed by thrombosis, pulmonary hypertension (PHT), abnormal liver function, and leg ulcers. Hypothyroidism, heart failure, and diabetes mellitus were less frequently observed. On multivariate analysis, older age and splenectomy were independently associated with an increased risk of most disease-related complications. Transfusion therapy was protective for thrombosis, EMH, PHT, heart failure, cholelithiasis, and leg ulcers. However, transfusion therapy was associated with an increased risk of endocrinopathy. Iron chelation therapy was in turn protective for endocrinopathy and PHT. Hydroxyurea treatment was associated with an increased risk of hypogonadism yet was protective for EMH, PHT, leg ulcers, hypothyroidism, and osteoporosis. Attention should be paid to the impact of age on complications in TI, and the beneficial role of splenectomy deserves revisiting. This study provides evidence that calls for prospective evaluation of the roles of transfusion, iron chelation, and hydroxyurea therapy in TI patients.
UR - http://www.scopus.com/inward/record.url?scp=77950420281&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950420281&partnerID=8YFLogxK
U2 - 10.1182/blood-2009-09-243154
DO - 10.1182/blood-2009-09-243154
M3 - Article
C2 - 20032507
AN - SCOPUS:77950420281
SN - 0006-4971
VL - 115
SP - 1886
EP - 1892
JO - Blood
JF - Blood
IS - 10
ER -